Zen - Investment Analysis
  • For Startups
    Startup Resources
    Investor Directory Startup Directory CRM
    Raise
    Profile Page Deck Analysis Pitch Simulator
  • For Investors
    Deal Management
    AI Deal Review Funnel Stages Criteria
    Team & Discover
    Team Management Investor Directory Investor Profile Startup Directory

Investor Directory Startup Directory CRM Profile Page Deck Analysis Pitch Simulator

AI Deal Review Funnel Stages Criteria Team Management Investor Directory Startup Directory
Login Register
Login Register
RECOMMENDED

Pro

$49/month
  • Pitch deck analysis
  • Full directory access
  • Show connections
  • Sort by connections
  • Unlimited Investor Outreach
  • Private deck sharing url
  • AI generated intro emails
  • Priority support

Payment Details

Loading...

Setting up payment...

An error occurred while setting up the payment.

Coupon Code
Pricing
Free

$0/mo

  • Create a startup profile
  • Share with investors
  • Basic analytics
Popular
Pro

$49/mo

  • All Free features
  • Advanced analytics
  • Priority support
Add/Claim Your Firm
PJT

Paul J Tiao

United States

About

Co-Founder and Managing Partner at Northpond Ventures, a life sciences venture capital firm. Focuses on R&D and diagnostic tools.

Additional Information

Investment Stages

Verticals

Biotechnology / Pharmaceuticals Healthcare Life Sciences Medical Devices

Investor Type

Angel Investor
Website Crunchbase

Get Venture Funding from Similar Investors

Oxford Innovation Finance
Oxford Innovation Finance

Investment Director at Oxford Innovation Finance (OIF), managing the OION EIS Growth Fund and angel network investments.

Specialist VC
Specialist VC

Partner at Specialist VC, focusing on deep tech from Baltics & Ukraine. Background in human genetics (Estonian Biobank, UT Tartu). Invests via Specialist VC.

Conduit Ventures Ltd
Conduit Ventures Ltd

Investment Principal at M Ventures (Merck KGaA's corporate VC arm), focusing on investments in Healthcare, Life Science, Electronics, and Frontier Tech.

Ocunexus
Ocunexus

President and CEO of Ocunexus Therapeutics, a clinical-stage biopharmaceutical company. Previously held leadership roles at Aerie Pharmaceuticals and other ophthalmology-focused companies. Focus on biotechnology and pharmaceuticals.

Connect

Interested in connecting with this investor?

Find an intro Pro
Accounts
  • Login
  • Register
  • Profile
Plans
  • Venture Plans
  • Startup Plans
Company
  • Contact us
  • Support
  • FAQ
  • Blog
Legal
  • Terms of Service
  • Privacy Policy
Current page added:
We use cookies to ensure you get the best experience on our website.
Learn more

Let's get this going!
First off let's set up an account.

Login Register